Skip to content

Biohaven BHVN Income Tax

Income Tax at other companies

Eli Lilly logo
Eli LillyLLY
$1.45B+109%
Xenon Pharmaceuticals logo
Xenon PharmaceuticalsXENE
-$2.57M-702%
Vir Biotechnology, Inc. logo
Vir Biotechnology, Inc.VIR
$170K+963%
uniQure logo
uniQureQURE
$488K-1.6%
Protagonist Therapeutics logo
Protagonist TherapeuticsPTGX
-$1.5M
Monte Rosa Therapeutics, Inc. logo
Monte Rosa Therapeutics, Inc.GLUE
$52K-93.7%

Segments

By segment

See full
Reportable Segment$272K-55.3%

Other financials

Income statement

See full
Operating income-$130.4M+41.1%
Net income-$130.5M+41.1%
EPS (diluted)-$0.88+59.4%

Balance sheet

See full
Cash & equivalents$277.1M+170%
Total debt$286.2M+706%
Total equity$129.5M-50.1%
Total assets$466.4M+1.6%

Cash flow

See full
Operating cash flow-$149.9M+9.2%
CapEx--100%
Free cash flow-$149.9M+9.5%

Valuation

See full
Market cap$2.25B-48.1%
Enterprise value$2.26B-46.3%

Returns & leverage

See full
Return on equity-333%+17.9pp
Debt / equity2.2×+2.1×
Current ratio7.4×+5.1×

Where this comes from

Reported directly by Biohaven in its filing.

Tagged under the XBRL concept us-gaap:IncomeTaxExpenseBenefit.

The official record: Biohaven’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →

Ask your AI about Biohaven's income tax.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Biohaven's income tax?
Biohaven (BHVN) reported income tax of $272K in Q1 2026.
How has Biohaven's income tax changed year-over-year?
Biohaven's income tax decreased by 55.3% year-over-year, from $609K to $272K.
What is the long-term trend for Biohaven's income tax?
Over 2 years (2023 to 2025), Biohaven's income tax has grown at a 2.1% compound annual growth rate (CAGR), from -$1.38M to $1.44M.
What does income tax mean?
Total income tax expense (current + deferred) recognized in the income statement, representing the company's total tax obligation on pre-tax income.